By: Tom Snee | 2017.02.02 | 01:02 pm
Patients taking a new class of drugs to reduce cholesterol do not experience an increase in side effects like memory impairment or nervous system disorders, but may have an increased risk of cataracts, according to a study led by a UI College of Public Health researcher.
Roaming cardiologists increase rural Iowans' access to specialized heart care by 33 percent
By: Tom Snee | 2016.08.25 | 08:26 am
Rural patients with heart disease often have limited access to specialized care because most cardiologists practice in cities, but a new study from the University of Iowa finds that the use of visiting consultant clinics (VCCs) in rural hospitals staffed by traveling cardiologists greatly increases access to care.
By: UI Health Care Marketing and Communications | 2016.05.05 | 09:50 am
Ryan Boudreau, UI assistant professor of internal medicine, has received a three-year, $438,657 Young Investigator award from the Roy J. Carver Charitable Trust to investigate regulatory mechanisms that control when and where proteins are made within heart cells.
External Media | 2015.03.23 | 12:15 pm
A new study from lead investigator Jennifer Robinson, an epidemiologist in the College of Public Health, shows that a cholesterol drug may also be able to reduce heart attacks and strokes.
Center renamed the Francois M. Abboud Cardiovascular Research Center
By: Tom Moore | 2013.12.04 | 01:46 pm
The Board of Regents, State of Iowa, today (Wednesday, Dec. 4) approved a request from the University of Iowa to re-name the UI Cardiovascular Research Center in honor of its founder, Francois Abboud, M.D.
New technique from UI study uses finger's pulse to measure stiffness in the aorta
By: Jennifer Patterson | 2013.09.04 | 08:00 am
A University of Iowa physiologist has a new technique to measure the stiffness of the aorta, a common risk factor for heart disease. The procedure involves measuring the pulse in the finger or on the arm, combined with an individual’s age and body mass index. Results are published in the “American Journal of Physiology Heart and Circulatory Physiology.”
University of Iowa team finds enzyme in airway lining cells could hold key for asthma sufferers
By: Richard C. Lewis | 2013.07.24 | 01:03 pm
A University of Iowa-led team has found a promising, new way to treat asthma: Target an enzyme in airway lining cells. The finding could lead to the development of drugs that block the enzyme, CaMKII, from excessive oxidation, which can trigger asthma attacks.
Targeting pathway may lead to better hypertension treatments for at-risk patients
By: Jennifer Brown | 2013.04.11 | 11:02 am
A University of Iowa study identifies a brain protein that acts as a communications hub for blood pressure control, and links cardiovascular disease and obesity to hypertension.
Overactive enzyme may be factor
By: Jennifer Brown | 2013.02.15 | 11:40 am
Having diabetes doubles a person’s risk of dying after a heart attack, but the reason for the increased risk is not clear. A new University of Iowa study suggests the link may lie in the over-activation of an important heart enzyme, which leads to death of pacemaker cells in the heart, abnormal heart rhythm, and increased risk of sudden death in diabetic mice following a heart attack.